This inventor holds 1 USPTO granted patent. Top assignees: Eli Lilly and Company, Shionogi Company Limited. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2000
Title: The Innovations of William Lester Confer
Introduction
William Lester Confer is an accomplished inventor based in Indianapolis, IN (US). He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of compositions that aid in medical treatments. His innovative work has led to the creation of a patented pharmaceutical composition that addresses critical health issues.
Latest Patents
William Lester Confer holds a patent for a pharmaceutical composition containing a phospholipase inhibitor. The patent describes a lyophilized pharmaceutical composition that includes Sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1H-indol-4-yl]oxy]acetate, a solubilizer, and a stabilizer. This composition is designed to be storage stable and readily dissolves in an aqueous medium, resulting in an injectable solution for the treatment of sepsis and other medical conditions. He has 1 patent to his name.
Career Highlights
Throughout his career, William has worked with notable companies in the pharmaceutical industry. He has been associated with Shionogi & Company Limited and Eli Lilly and Company, where he contributed to various projects and advancements in drug development. His expertise in pharmaceutical compositions has made a significant impact in the field.
Collaborations
William has collaborated with various professionals in his field, including his coworker Hideaki Tai. Their joint efforts have furthered the development of innovative pharmaceutical solutions.
Conclusion
William Lester Confer's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments. His patented work and collaborations highlight the importance of innovation in addressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile